Partner Investment Management’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Partner Investment Management’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13,260	Closed	-$12K	–	109
2019 Q2	$12K	Buy	13,260 +13	+0.1%	+$20	0.01%	81
2019 Q1	$31K	Sell	13,247 -2,036	-13%	-$5.52K	0.04%	89
2018 Q4	$35K	Hold	15,283	–	–	0.04%	81
2018 Q3	$226K	Sell	15,283 -2,060	-12%	-$32.7K	0.17%	94
2018 Q2	$263K	Hold	17,343	–	–	0.21%	91
2018 Q1	$326K	Sell	17,343 -283,568	-94%	-$4.96M	0.35%	68
2017 Q4	$5.07M	Sell	300,911 -29	-0%	-$613	5.84%	1
2017 Q3	$6.7M	Buy	+300,940	New	+$6.61M	6.35%	2

Other funds holding SNNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $1.1B AUM 27.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Partner Investment Management's SNNA Position: Q3 2019 in Review

Partner Investment Management sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q3 2019, closing a stake of 13,260 shares — an estimated $12K sold.

Partner Investment Management first reported a position in SNNA in Q3 2017 and held it in 8 quarters. The position peaked at $6.7M in Q3 2017. 23 funds tracked by Wall St. Rank hold SNNA as of Q3 2019.

Partner Investment Management reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Partner Investment Management sold 13,260 Sienna Biopharmaceuticals, Inc. shares in Q3 2019, an estimated $12K.
Partner Investment Management first reported a position in Sienna Biopharmaceuticals, Inc. in Q3 2017 and held it in 8 quarters.
Partner Investment Management's Sienna Biopharmaceuticals, Inc. position peaked at $6.7M in Q3 2017.
23 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q3 2019.

Based on Partner Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.